Ireland’s cervical cancer rates are continuing to fall, according to the HSE’s latest progress report published on World Cervical Cancer Elimination Day. The figures show further improvement in screening, treatment and HPV vaccination, although continued participation will be needed if cervical cancer is to become rare in every community by 2040.
Cervical cancer rates move closer to the 2040 goal
The average annual cervical cancer incidence rate fell to 10.2 new cases per 100,000 women in 2022–2024, down from 11 cases per 100,000 in 2021–2023. The World Health Organisation defines elimination as fewer than four cases per 100,000 women.
The HSE says Ireland remains on track, provided vaccination, screening and treatment services are sustained. The latest report highlights progress across all three areas:
- Screening: approximately three in four eligible women have had cervical screening in the past five years.
- Treatment: almost 97% of women diagnosed with cervical cancer receive treatment within one year.
- HPV vaccination: around eight in 10 girls have been vaccinated by age 14, compared with the WHO target of nine in 10.
HPV vaccination remains central to cervical cancer prevention
The HSE offers the HPV vaccine to boys and girls in first year of secondary school. The vaccine protects against the types of human papillomavirus that cause most cervical cancers and can also help prevent anal, penile, vulval, vaginal and some head and neck cancers.
More than 2,000 young people who previously missed vaccination have now received it through the Laura Brennan HPV School Catch-up Programme. The programme is available to eligible pupils in second to fifth year of secondary school, as well as certain home-educated young people born between 1 September 2008 and 31 August 2013.
Expanded access to cervical screening
Cervical screening is now available through 37 additional services, compared with eight in 2023. These include sexual health services, prisons, student health services and organisations supporting women experiencing homelessness.
The HSE is also preparing to invite women to take part in a study examining how self-sampling could be introduced into the national screening programme. However, vaccination and screening do not prevent every cervical cancer. The HSE advises anyone with possible symptoms to contact their GP promptly.
One action can support Ireland’s elimination target
On World Cervical Cancer Elimination Day, the HSE is encouraging people to take one practical step:
- Ensure eligible children receive their HPV vaccine.
- Book a cervical screening test when it is due.
- Attend any recommended follow-up appointments or treatment.
The latest figures show meaningful progress, but the 2040 target depends on maintaining high uptake and ensuring services remain accessible. For families and eligible women, vaccination, screening and timely treatment are the clearest ways to support Ireland’s cervical cancer elimination programme.





